News & Events

August 7, 2017

Alkahest Appoints Helen Jenkins as Chief Operating Officer

SAN CARLOS, Calif. — Alkahest Inc. (“Alkahest”), a clinical-stage biotechnology company focused on developing new treatments for neurodegenerative diseases and other age-related conditions, announced today that Helen Jenkins, has joined the company’s executive team as Chief Operating... Continue Reading

January 23, 2017

Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer

SAN CARLOS, Calif. — Alkahest Inc. (“Alkahest”), a biotechnology company focused on developing innovative treatments for neurodegenerative diseases and other age-related conditions, announced today that Sam Jackson, MD, MBA, has joined the company as Chief Medical Officer. In this role,... Continue Reading